OncoGenex Pharmaceuticals (OGXI)

Add to Watchlists
Create an Alert
3.23 -0.01  -0.31% NASDAQ Jul 31, 11:23 Delayed 2m USD
View Full Chart
OGXI Price Chart
View All Events

OGXI Events

Date Type Description
05/14/2015 16:30 EDT Misc OncoGenex Pharmaceuticals Inc First Quarter Earnings Results in 2015
05/14/2015 Earnings OncoGenex Pharmaceuticals Inc First Quarter Earnings Results in 2015 Release
03/26/2015 16:30 EDT Misc OncoGenex Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2014
03/26/2015 Earnings OncoGenex Pharmaceuticals Inc Fourth Quarter Earnings in 2014 Release
10/30/2014 16:30 EDT Misc Q3 2014 OncoGenex Pharmaceuticals Inc Earnings Conference Call
10/30/2014 Earnings Q3 2014 OncoGenex Pharmaceuticals Inc Earnings Result
08/07/2014 16:30 EDT Misc Q2 2014 OncoGenex Pharmaceuticals Inc Earnings Conference Call
08/07/2014 Earnings Q2 2014 OncoGenex Pharmaceuticals Inc Earnings Results
View All Performance Charts

OGXI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). OncoGenex Pharmaceuticals is up 4.87% over the last year vs S&P 500 Total Return up 9.39%, ISIS Pharmaceuticals up 72.74%, and Actinium Pharmaceuticals down 67.66%.

Advertisement

OGXI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.oncogenex.com
  • IR Website: http://ir.oncogenex.com/index.cfm
  • HQ Country: United States
  • HQ State/Province: Washington
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

OncoGenex Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the development & commercialization of therapies that address treatment resistance in cancer patients. It has three product candidates including custirsen, apatorsen & OGX-225.

OGXI Excel Add-In Codes

  • Name: =YCI("OGXI","name")
  • Description: =YCI("OGXI","description")
  • Sector: =YCI("OGXI","sector")
  • Industry: =YCI("OGXI","industry")
  • Est. Current Fiscal Year End: =YCI("OGXI","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.